Operator: Good afternoon, and welcome to Lumos Pharma s Q2 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode.
Operator: Good afternoon, and welcome to Lumos Pharma s 2022 Financial Results Conference Call. We ll now turn the call over to Lisa Miller, Senior Director of Investor Relations.
Lumos Pharma Announces Retirement of Carl Langren and Names Lori Lawley Chief Financial Officer in Planned Succession streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ADCT) - The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche s Diagnostics Business Comes to Rescue benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.